PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...
GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...
GLP-1 drugs used for weight loss involve all kinds of side effects ... include Ozempic and Wegovy (semaglutide), Victoza and Saxenda (liraglutide), and Mounjaro and Zepbound (tirzepatide).) ...
The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...
Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...
The company behind popular weight-loss drugs failed to disclose even more ... Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose ...